Zobrazeno 1 - 10
of 607
pro vyhledávání: '"S H, van der Burg"'
Autor:
S. J. Santegoets, C. L. Duurland, E. S. Jordanova, J. J. van Ham, I. Ehsan, S. L. van Egmond, M. J. P. Welters, S. H. van der Burg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Regulatory T cells (Tregs) may comprise different subsets allowing them to efficiently suppress different types of effector T cells. In this study, we show that high numbers of both conventional and Tbet co-expressing Foxp3hi Tregs accumulat
Externí odkaz:
https://doaj.org/article/62868b7ab4e84d2c8edcadb20c09e374
Autor:
S. J. A. M. Santegoets, A. F. de Groot, E. M. Dijkgraaf, A. M. Carnaz Simões, V. E. van der Noord, J. J. van Ham, M. J. P. Welters, J. R. Kroep, S. H. van der Burg
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
Epithelial ovarian cancer (EOC) may cause abnormal blood levels of leukocytes. This paraneoplastic manifestation is associated with a worse response to therapy and shorter survival. To understand the complexity and nature of these leukocytes, we diss
Externí odkaz:
https://doaj.org/article/f4b6784697f04c0297d742904ad36aca
Autor:
H. van Meir, R. A. Nout, M. J. P. Welters, N. M. Loof, M. L. de Kam, J. J. van Ham, S. Samuels, G. G. Kenter, A. F. Cohen, C. J. M. Melief, J. Burggraaf, M. I. E. van Poelgeest, S. H. van der Burg
Publikováno v:
OncoImmunology, Vol 6, Iss 2 (2017)
New treatments based on combinations of standard therapeutic modalities and immunotherapy are of potential use, but require a profound understanding of immune modulatory properties of standard therapies. Here, the impact of standard (chemo)radiothera
Externí odkaz:
https://doaj.org/article/9ab1477d33ed4379aebc6f6b01ce1a4c
Autor:
G, de Jong, L, Bartels, M, Kedde, E M E, Verdegaal, M A, Gillissen, S E, Levie, M G, Cercel, S E, van Hal-van Veen, C, Fatmawati, D, van de Berg, E, Yasuda, Y B, Claassen, A Q, Bakker, S H, van der Burg, R, Schotte, J, Villaudy, H, Spits, M D, Hazenberg, P M, van Helden, K, Wagner
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(6)
Targeted cancer therapy with monoclonal antibodies has proven successful for different cancer types but is limited by the availability of suitable antibody targets. CD43s, a unique sialylated form of CD43 expressed by hematologic malignancies, is a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b8e54519e3170d936b9527cd4d02912
https://pubmed.ncbi.nlm.nih.gov/33225419
https://pubmed.ncbi.nlm.nih.gov/33225419
Autor:
H, Van Meir, I J, du Burck, M L, de Kam, M J P, Welters, S H, van der Burg, J B M Z, Trimbos, C D, de Kroon, M I E, van Poelgeest
Publikováno v:
European journal of gynaecological oncology. 38(1)
To investigate prognostic factors in patients with recurrent cervical cancer after treatment of early-stage disease in order to identify high-risk patients who might benefit from alternative treatment strategies.The authors retrospectively analyzed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::004ac7d856ccdf21ef585afc968e052b
https://pubmed.ncbi.nlm.nih.gov/29767860
https://pubmed.ncbi.nlm.nih.gov/29767860
Autor:
He, Jide1 (AUTHOR), Wu, Jialong1 (AUTHOR), Li, Ziang1 (AUTHOR), Zhao, Zhenkun1 (AUTHOR), Qiu, Lei1 (AUTHOR), Zhu, Xuehua1 (AUTHOR), Liu, Zenan1 (AUTHOR), Xia, Haizhui1 (AUTHOR), Hong, Peng1 (AUTHOR), Yang, Jianling2 (AUTHOR), Ni, Ling3 (AUTHOR) lingni@tsinghua.edu.cn, Lu, Jian1,4 (AUTHOR) lujian@bjmu.edu.cn
Publikováno v:
Cancer Medicine. Oct2024, Vol. 13 Issue 20, p1-13. 13p.
Autor:
Kim, Jaehyun1 (AUTHOR), Kang, Seyoung1 (AUTHOR), Kim, Jisu1 (AUTHOR), Yong, Seok‐Beom2 (AUTHOR), Lahiji, Shayan Fakhraei1,3 (AUTHOR), Kim, Yong‐Hee1,3,4 (AUTHOR) yongheekim@hanyang.ac.kr
Publikováno v:
Advanced Science. 9/25/2024, Vol. 11 Issue 36, p1-12. 12p.
Autor:
Lv, Linwen1,2 (AUTHOR), Zhang, Junzhe3 (AUTHOR), Wang, Yujiao1 (AUTHOR), Liang, Haojun1 (AUTHOR), Liu, Qiuyang1 (AUTHOR), Hu, Fan1 (AUTHOR), Li, Hao1 (AUTHOR), Su, Wenxi1 (AUTHOR), Zhang, Junhui1 (AUTHOR), Chen, Ranran1 (AUTHOR), Chen, Ziteng1 (AUTHOR), Wang, Zhijie1 (AUTHOR), Li, Jiacheng1 (AUTHOR), Yan, Ruyu1 (AUTHOR), Yang, Mingxin1 (AUTHOR), Chang, Ya‐nan1 (AUTHOR), Li, Juan1 (AUTHOR), Liang, Tianjiao4 (AUTHOR) liangtj@ihep.ac.cn, Xing, Gengmei1 (AUTHOR) xinggm@ihep.ac.cn, Chen, Kui1 (AUTHOR) chenkui@ihep.ac.cn
Publikováno v:
Advanced Science. 9/18/2024, Vol. 11 Issue 35, p1-13. 13p.
Autor:
An, Xian1 (AUTHOR), Chen, Zhuang2 (AUTHOR) chenzhuang@xidian.edu.cn, Luo, Yi2 (AUTHOR), Yang, Peng2 (AUTHOR), Yang, Zuo2 (AUTHOR), Ji, Tiannan3 (AUTHOR), Chi, Yajing4 (AUTHOR), Wang, Shuyuan1,4 (AUTHOR), Zhang, Ruili2 (AUTHOR) rlzhang@xidian.edu.cn, Wang, Zhongliang2 (AUTHOR) wangzl@xidian.edu.cn, Li, Jianxiong1 (AUTHOR) 301301ljx@sina.com
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-14. 14p.
Autor:
Luo, Ziheng1,2 (AUTHOR), Cheng, Xiang1,2 (AUTHOR), Feng, Bin1,2 (AUTHOR), Fan, Duoyang1,2 (AUTHOR), Liu, Xiaohui1,2 (AUTHOR), Xie, Ruyan1,2 (AUTHOR), Luo, Ting1,2 (AUTHOR), Wegner, Seraphine V.3 (AUTHOR), Ma, Dayou2 (AUTHOR), Chen, Fei1,2 (AUTHOR) fechen@csu.edu.cn, Zeng, Wenbin1,2 (AUTHOR) wbzeng@csu.edu.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-30. 30p.